Seaside 88, LP Suite 805 North Palm Beach, FL 33408Letter Agreement • September 22nd, 2010 • Nanoviricides, Inc. • Services-commercial physical & biological research
This Letter Agreement and Amendment is to confirm the option exercise of Seaside 88, LP (the “Purchaser”), pursuant to Section 2.3 of the Agreement, to purchase an additional 500,000 shares of the Series B Stock of NanoViricides, Inc. (the “Company”) in the Follow-On Offering pursuant to the terms set forth in the Agreement, as amended hereby. Capitalized terms used herein without definition shall have the meanings ascribed to such terms in the Agreement.
